Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 11619
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
68722
Mo......great well written post! Thanks for
(2)
falcon74
02/25/2021 10:05:29 PM
68721
The New York variant of the virus may not be
(9)
Drano
02/25/2021 8:27:43 PM
68719
I mostly agree with your statement about criminal
(22)
Mo
02/25/2021 3:41:13 PM
68718
Existing indications repurposed to battle
(5)
crashco
02/25/2021 2:44:24 PM
68715
GSK Phase 2 Otilimab fails to meet Primary end
crashco
02/25/2021 2:33:35 PM
68713
Hi Jim, the User who authored that post is
BooDog
02/25/2021 11:10:50 AM
68712
admins over there must be making bank deleting
(1)
BooDog
02/25/2021 10:51:17 AM
68709
Here is a post by JFM on IFUD this morning that
(11)
falcon74
02/24/2021 5:11:33 PM
68707
I don't think uplisting is what will cut down on
(8)
petemantx
02/24/2021 3:56:18 PM
68706
I cant wait until we up-list. The manipulation
(4)
stocker11
02/24/2021 3:48:07 PM
68705
Remember that some time ago it was mentioned
(3)
Drano
02/24/2021 11:49:25 AM
68704
That is good to know as it seems it has taken
(2)
petemantx
02/24/2021 11:21:14 AM
68703
Agree , only posted that link to show what other
NotRichYet2
02/24/2021 9:57:07 AM
68702
Unlike the vaccines that require a specialized
(8)
Drano
02/24/2021 9:37:46 AM
68701
Kind of like predicting a car's time at the drag
(5)
petemantx
02/24/2021 9:35:44 AM
68700
Makes me also wonder if the foreign part of the
(3)
petemantx
02/24/2021 9:22:42 AM
68698
Here is a computerized ANALISIS of IPIX's
(1)
NotRichYet2
02/24/2021 8:27:13 AM
68696
Why is the phII trial not on clinicaltrials . gov
kerdom
02/24/2021 8:14:44 AM
68695
Awesome post Mo! I see it playing out pretty much
(5)
Ultimate
02/24/2021 7:31:35 AM
68693
My opinion on the number of B-CV19 trials is as
(20)
Mo
02/24/2021 1:11:57 AM
68692
I agree that Leo has missed a few PR
(1)
thefamilyman
02/24/2021 12:57:59 AM
68691
Leo put out quite a few PRs last year. Many some
(2)
Commando911
02/23/2021 11:47:56 PM
68690
Thank-you Pete, as usual a killer
angeli
02/23/2021 10:47:57 PM
68688
My take on "the market" is that retail are pawns
(11)
petemantx
02/23/2021 7:10:01 PM
68686
Speculation: I am also intrigued by the word
(4)
doubleJ23
02/23/2021 1:23:51 PM
68685
Ive been checking that site regularly.
Patchesohoulihan
02/23/2021 11:21:13 AM
68682
"it wont be long before we hear something."
(7)
farrell
02/23/2021 10:54:06 AM
68681
Don't get all hung up trying to parse language.
(4)
Drano
02/23/2021 10:23:05 AM
68680
Like I mentioned before, I also want additional
(6)
Ultimate
02/23/2021 10:10:32 AM
68678
Hi all, I'm trying to do some DD and see if there
(2)
doubleJ23
02/23/2021 9:46:24 AM
68675
A good and respected friend sent me this note
(10)
petemantx
02/22/2021 8:19:20 PM
68674
My take on todays events and 10-Q filing is
(13)
Mo
02/22/2021 5:47:17 PM
68673
I think the FDA is going to be trying very hard
(5)
Drano
02/22/2021 4:42:33 PM
68672
Just saw Fauci giving an update with a lot of
(4)
Chemdeps
02/22/2021 4:03:31 PM
68671
With the amount of people needed to fill the 120
(2)
petemantx
02/22/2021 3:56:07 PM
68670
Thats exactly as I see it. We are out of 1st
(2)
Ultimate
02/22/2021 3:00:50 PM
68669
Last week there was a document that showed 17, so
Drano
02/22/2021 2:48:13 PM
68668
Drano......I agree that common sense would tell
(1)
falcon74
02/22/2021 2:10:23 PM
68667
There are 17 clinical trial sites in Russia. I
(1)
Drano
02/22/2021 1:38:59 PM
68666
Chem---- I completely agree with your
(5)
falcon74
02/22/2021 1:04:10 PM
68665
I thought the statement that the phase II trials
(3)
Chemdeps
02/22/2021 12:52:08 PM
68664
Pete From the AS agreement. (i) Development
(3)
bettingbig
02/22/2021 12:18:54 PM
68663
Here's a list of "highlights" from the 10Q that I
(6)
Drano
02/22/2021 12:02:10 PM
68661
Is a successful P1 by AS considered a milestone
(1)
petemantx
02/22/2021 11:50:58 AM
68659
A little something MORE to look forward to.
(4)
NotRichYet2
02/22/2021 11:45:20 AM
68658
Excellent news! I thought covid impacted the
(7)
Ultimate
02/22/2021 11:44:47 AM
68657
"The Company is collaborating with a Regional
(10)
Drano
02/22/2021 11:44:07 AM
68656
10Q great news: " In January 2021, Alfasigma
(10)
Drano
02/22/2021 11:41:44 AM
68654
A phase2/3 or 3 wouldnt be possible if there
(2)
Ultimate
02/22/2021 11:19:04 AM
68651
Perhaps they are testing for other viruses also.
Fit007
02/22/2021 10:02:20 AM
Newer
Older
Recent Articles
Gran Tierra Energy's New Oil Discovery and Strategic Partnership
Transforming the Events Industry: Rhuna Partners with Plume
ANI Pharmaceuticals Prepares for Piper Sandler Healthcare Conference
Ultragenyx Pharmaceutical's Upcoming Investor Conferences in December
Exela Technologies Outlines Plans for Upcoming Earnings Call
Cansortium Expands Financial Flexibility with New Credit Deal
Aclaris Therapeutics to Showcase Innovations at Major Conference
YXT.com Unveils Key Leadership Changes to Drive Growth
Mazarin Inc. Welcomes New CFO Amid Strategic Changes
Mazarin Inc. Grants Stock Options to Enhance Share Value
Autodesk Delivers Impressive Q3 Earnings Report
Nutanix Reports Strong Q1 Earnings Performance and Growth
Urbanfund Corp. Reports Impressive Financial Performance
Ambarella Inc Achieves Impressive Q3 Results, Stock Rises
Yelp Acquires RepairPal for Strategic Expansion in Services
TechTarget's Merger with Informa: A Game-Changer in B2B
Onco360 Partners with BrightSpring for Innovative Cancer Therapies
How Tariff Policies Shape Global Currencies and Markets
Impact of US Tariffs on Global Economic Growth Raises Concerns
Autodesk Surpasses Q3 Earnings Expectations with Key Metrics
X Financial Sees Growth in Q3 2024 Results Amid Strong Demand
Workday Reports Robust Q3 Earnings Performance and Growth
3D Systems Reports Q3 Earnings: Insights and Analysis
Minerals Technologies Strengthens Financial Position with New Loan
Couchbase Rewards New Employees with Equity Incentives
Join the Exciting December 2024 Shipping Webinars Today!
Newmont's Strategic Moves: Cashing in on Non-Core Assets
Partsol Partners with the US Army for Innovative AI Services
Lawmakers Urge Biden to Expand Cannabis Clemency Efforts
Humacyte, Inc. (HUMA) Faces Class Action in Major Legal Move
Autodesk Reports Q3 Earnings: Insights and Future Outlook
Legal Action Alert for Investors in Zeta Global Holdings, Corp.
Celsius Holdings, Inc. Class Action: Key Details for Investors
Investors Alerted: Class Action for Xerox Holdings Corporation
Workday's Q3 Performance Shows Resilience Amid Challenges
Evelyn Angelle Joins Bird Construction's Board of Directors
Supernus Pharmaceuticals Set for Engaging Healthcare Conference
Impact of Trump's Tariff Plans on Canadian Dollar and Peso
Investors Explore Class Action Against Paragon 28, Inc.
Unlocking Legal Insights: Join the Fight with Xerox Investors
Alison Voorhees Appointed as SVP and Marketing Director at Bank
Nutanix Achieves Impressive Growth in Q1 Fiscal 2025 Results
Autodesk Reports Strong Third Quarter Results for Fiscal 2025
Workday's Impressive Growth in Q3 and Future Prospects
Portage Biotech's Latest Financial Update Highlights Progress
Ambarella Reports Impressive Revenue Growth in Q3 2025
Urban Outfitters Achieves Impressive Q3 Revenue and Profit
Nordstrom Inc. Reports Strong Q3 Earnings and Growth Trends
Surprising Crude Inventory Drop Signals Strong Oil Demand Surge
Burlington Welcomes New Board Member, Former Staples CEO Shira Goodman